1 BIOSKETCH: is a Professor (tenured) of Urology & Cancer Biology at the University of Kansas Dr Benyi Li Full Medical Center (KUMC) and the Director for Basic Research at the KUMC Department of Urology. Dr Li received his medical training from Tongji Medical University of China at 1992 and PhD of Tumor Biology from Fukui University of Japan at 1997. After postdoc trainings from he joined the Moffitt Cancer Center at Tampa and Baylor College of Medicine at Houston, KUMC Urology at the end of 2001. RESEARCH INTERESTS: As a physician - scientist, Dr Li has been engaged in bas ic and translational research on several urological diseases including kidney stone disease, benign prostatic hyperplasia, bladder renal cancer, cancer and prostate cancer in addition to his clinical work in his early career Since 2002, ed his career on prostate cancer research to identify critical period. Dr Li focus signal pathways or therapeutic targets for therapy development. Multiple novel therapeutic approaches were developed from his group for human prostate cancer, such as PI3K/p110beta specific inh ibitors and androgen receptor silencing RNAs. Very recently, Dr Li is using a novel RNA activation approach to develop a small RNA therapy for metastasis prevention by increasing DPYSL3 gene expression, which is a tumor metastasis suppressor gene in prosta te cancers. - drug for a Also, he is exploring a novel organic molecule Alternol as a new chemo variety of human cancers. VISION: Dr Li has been a member of SBUR through AUA for a long time and he has numerous - he served as the in organizing scientific society . For example, first hand experiences resident of KUMC Chapter of the SigmaXi Society P - elect and then P Secretary, resident during 2005 - 2008. Dr Li has been actively involved in organizing local and national scientific meetings in cluding SBUR 2014 fall symposium , 2016 S pring conference and the annual meetings of World Association of Chinese Urologists in last 8 years . Since the importance of the SBUR financial situation, the Treasure position is critical for our continuing success to serve our members and the academic society. It will be essential to work with other board members as a team to facilitate our effort s in fund - raising and to maximize our potential with resources available . We will also need to advocate loudly for resear ch funding support for our members at all levels. For sure a hard work plus multiple clever approaches are the keys for our continuation as a successful society! Dr Li will dedicate his compassion and energy to the SBUR society.
Chemicals from Biomass: Market Assessment of A -T erm ear ioproducts with N B P otential and Mary J. Biddy, Christopher Scarlata, Christopher Kinchin National Renewable Energy Laboratory NREL is a nat...More info »
Intel® Server Board S 2600 WF Product Family Technical Product Specification An overview of product features, functions, architecture, and support specifications. 2.2 Rev April 2019 Intel® Server Prod...More info »
Clinical Development Success Rates 2006-2015 Biomed trac ke r Pharma intelligence | June 2016More info »
Takara Bio USA , Inc. Clontech® PCR - Select™ Differential Screening User Manual Kit Cat. No . 63740 3 ) ( 0 30218 T k a r a B i a o U S A , Inc. 1290 Terra ella Avenue, Mountain View, CA 94043, USA B...More info »
Takara Bio USA , Inc. SMARTer® Mouse BCR IgG H/K/L Profiling Kit User Manual Cat. No . 634422, 634423, 634424 s ) 17 1212 ( , Inc. Takara Bio USA 1290 Terra Bella Avenue, Mountain View, CA 94043, USA ...More info »
United States Department of Agriculture An Economic Impact Analysis of the U.S. Biobased Products Industry A Report to the Congress of the United States of AmericaMore info »